안과용 의료기기 시장 : 제품 유형별, 용도별, 최종 용도별, 지역별(2026-2034년)

The global ophthalmic devices market size reached USD 29.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 40.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.38% during 2026-2034. The market is propelled by the expanding geriatric population, rising prevalence of eye ailments, and the growing medical tourism sector which is driving innovation and investment in advanced eye care technologies.

OPHTHALMIC DEVICES MARKET ANALYSIS:

• Major Market Drivers: The increasing prevalence of cataracts, glaucoma, and diabetic retinopathy, and several technological advancements in devices such as optical coherence tomography and femtosecond lasers are bolstering diagnosis and treatment outcomes, which are driving ophthalmic devices demand.
• Key Market Trends: The increasing use of minimally invasive surgery in treatment for several of the above eye conditions has brought much innovation in surgical devices and procedures. Additionally, utilization of teleophthalmology has seen increased acceptance in remote areas for remote diagnosis and consultation, which is widening market horizons.
• Geographical Trends: The ophthalmic devices market forecasts indicate significant growth, particularly in emerging economies including Asia-Pacific and Latin America regions. These increases will be primarily driven by improving healthcare conditions and greater disposable income. Meanwhile, North America and Europe remain solid leaders in the market, primarily due to high healthcare budgets and early adoption of new technology trends.
• Competitive Landscape: Some of the major ophthalmic devices companies include Alcon Inc, Bausch + Lomb Surgical, EssilorLuxottica SA, Haag-Streit Group, HOYA Surgical Optics, Leica Microsystems, Nidek Co., Ltd., Topcon Corporation, Volk Optical, ZEISS Medical Technology and Ziemer Ophthalmic Systems AG, among many others.
• Challenges and Opportunities: As per the ophthalmic devices market outlook, the high cost of ophthalmic devices presents a significant challenge, especially in developing regions where affordability is a major concern. This issue arises as many developing countries struggle with the financial burden of accessing advanced medical devices. Along with this, increased awareness about eye health and expanding government initiatives offer substantial opportunities for market growth, presenting potential areas for expansion.

OPHTHALMIC DEVICES MARKET TRENDS:

Growing Geriatric Population

The demographic scenario at a global stage is undergoing a major transformation with a remarkable upsurge in the geriatric population. According to the World Health Organization, demographic projections suggest that by 2030, individuals 60 years old and above will account for one-sixth of the global population. During these interim periods, the population within the 60-year-old and above is projected to grow from 1 billion as of 2020 to about 1.4 billion. Additionally, by 2050, the population in this geriatric group will double to about 2.1 billion. Moreover, the population of individuals within the 80-years-and-above category will triple from 2020 to 2050, leading to a change in its reach to about 426 million. As per the ophthalmic devices market overview, the surge in ocular disease, notably cataracts and glaucoma, among the geriatric population is reshaping the economy of ophthalmic devices.

Increasing Incidence of Eye Diseases

An increasing incidence of eye disorders is propelling the growth of the ophthalmic device market. Notably, an alarming increase in the prevalence of cataracts, which are a sight-threatening condition affecting millions of people, is influencing the market growth. According to the American Academy of Ophthalmology, 81% of Americans are familiar with eye health. However, four out of five people aged 40 and above cannot identify the three leading causes of blindness in the U.S. including glaucoma, age-related macular degeneration, and diabetic eye disease. Additionally, around 20.5 million Americans aged 40 and above, or 17.2% or 20.5 million, have been diagnosed with cataracts in one or both eyes. Presently, about 6.1 people, or 7%, have undergone cataract-removal surgery. Therefore, the above trend calls for robust interventions involving advanced ophthalmic devices to manage and treat such prevalent ocular conditions effectively.

Expanding Medical Tourism

The burgeoning medical tourism has emerged as a potent catalyst escalating the demand for ophthalmic devices on a global scale. With the allure of cost-effective yet high-quality healthcare services, patients increasingly seek elective procedures abroad, including refractive surgery and cosmetic eye treatments. In 2023, the global medical tourism market attained a valuation of US$ 119.7 Billion. IMARC Group anticipates that by 2032, this market will expand significantly to US$ 650.8 Billion, demonstrating a compound annual growth rate (CAGR) of 20.1% from 2024 to 2032. This trend is particularly pronounced in regions offering state-of-the-art ophthalmic facilities equipped with advanced devices and technologies. Consequently, ophthalmic clinics and healthcare facilities in medical tourism destinations are witnessing a surge in demand, driving investments in cutting-edge equipment and infrastructure. The convergence of healthcare expertise and affordability in these destinations not only fosters accessibility to specialized eye care but augments the market for ophthalmic devices, underlining the pivotal role of medical tourism in shaping the landscape of ophthalmology.

OPHTHALMIC DEVICES MARKET SEGMENTATION:

Breakup by Product Type:

• Surgical
  • Implants
  • Consumables
  • Equipment
• Vision Care
  • Contact Lens
  • Ocular Health

Vision care accounts for the majority of the market share

Vision care is emerging as the largest segment which includes an extensive range of products used for vision correction and enhancement with eyeglasses, contact lenses, and intraocular lenses. It caters to the needs of individuals with refractive errors, such as myopia, hyperopia, astigmatism, and presbyopia for corrective as well as preventive vision care. According to the National Eye Institute, more than 150 million Americans have a refractive error. Moreover, the increasing prevalence of refractive errors across the globe and rising awareness concerning eye health boost the scale of vision care products, thus fostering the scale of the ophthalmic devices market growth.

Breakup by Application:

• Cataract
• Vitreo Retinal Disorders
• Glaucoma
• Refractor Disorders

Cataracts are one of the common applications of the ophthalmic devices market due to the increasing incidence of cataracts and an aging population in various established economies of the world. There is a rising demand for devices that are used for cataract diagnosis and surgery. The devices comprise phacoemulsification systems, intraocular lenses (IOLs), and femtosecond lasers due to the increasing adoption of advanced surgical techniques and the history of premium IOLs offering better visual outcomes than conventional IOLs. Hence, market players are adding devices in their portfolio that can cure or manage cataract to expand their ophthalmic devices market share. For instance, on april 4, 2024, Carl Zeiss Meditec AG announced the acquisition of 100% Dutch Ophthalmic Research Center (D.O.R.C). It was acquired from the aforesaid investment firm Eurazeo SE, Paris, France which completes the extensive ophthalmic portfolio of ZEISS Medical Technology. The novel advances in eye health devices and digitally incorporated workflow solutions address a vast array of eye conditions, spanning retina and corneal diseases, cataracts, glaucoma, and refractive issues.

Vitroretinal disorders include various conditions related to the retina and vitreous humor such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal detachment. Ophthalmic devices used in the diagnosis and treatment of vitreoretinal disorders are optical coherence tomography (OCT) systems, laser photocoagulation equipment, and surgical instruments used in vitrectomy procedures. The increasing prevalence of AMD, diabetic retinopathy, and advancements in retinal imaging technology are escalating the demand for ophthalmic devices catering to this application.

Glaucoma is a common cause of irreversible blindness worldwide, which has led to the use of specialized ophthalmic devices for its diagnosis and management. For instance, tonometers for intraocular pressure (IOP) measurement, perimetry equipment for visual field testing, and minimally invasive glaucoma surgery (MIGS) devices are used to manage glaucoma. Also, the increasing prevalence of glaucoma, growing awareness, and screening programs are scaling the ophthalmic devices market recent opportunities.

Refractive errors, which include myopia, hyperopia, and astigmatism, are the most common vision problems and can be corrected with various ophthalmic techniques and devices. Ophthalmic devices used to correct refractive error include Excimer lasers used for LASIK and PRK procedures, phakic intraocular lenses (PIOLs), and corneal topography for preoperative evaluation. Besides this, the rising demand for refractive surgery owing to the increasing myopia rates and continuous advancement in surgical techniques, are propelling the market growth.

Breakup by End Use:

• Hospitals and Eye Clinics
• Academic and Research Laboratory
• Others

Hospitals and eye clinics represent the leading market segment

Hospitals and eye clinics are important centers for the diagnosis, treatment, and management of various eye conditions and diseases. Hospitals have state-of-the-art ophthalmic capability, and qualified personnel serve various categories of patients seeking eye care services from simple eye exams to complex surgeries. In line with this, eye clinics are centers founded to exclusively cater to eye-related problems and patients seeking specific interventions using varied technology. At present, hospitals and eye clinics are commonly visited facilities for comprehensive eye care functions which is generating enough ophthalmic devices market revenue.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The ophthalmic devices market report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The North America ophthalmic devices market recent developments are marked by advanced healthcare infrastructure, high healthcare expenditure, and the increasing prevalence of eye disorders among the aging population. The presence of sophisticated technology and a robust regulatory framework enhances the adoption of innovative ophthalmic devices in this region. Additionally, heightened awareness about eye health and the availability of government-backed reimbursement policies further stimulates market growth. For instance, in January 2024, Iridex Corporation, the global leader in the innovation of laser-based medical systems for treating eye diseases announced the US launch of its state-of-the-art platform, Iridex 532(R) and Iridex 577(R) Lasers.

In Europe, the ophthalmic devices market thrives due to a well-established healthcare system, a rising geriatric population, and a growing demand for advanced eye care solutions. Countries such as Germany, the UK, and France significantly contribute to market growth through their robust research and development (R&D) activities and favorable reimbursement policies. Furthermore, the presence of leading ophthalmic device manufacturers in this region promotes innovation and market expansion.

The Asia Pacific region is a growing market for ophthalmic devices owing to its large population base, increasing healthcare expenditure, and heightened awareness about eye health. Moreover, countries such as China, India, and Japan are experiencing significant growth in this market due to improved medical infrastructure and rising disposable incomes, which enable more people to afford these devices. Additionally, the increasing prevalence of eye disorders such as cataracts and glaucoma among the aging population is propelling market growth.

In Latin America, the ophthalmic devices market is growing steadily owing to enhanced access to healthcare services, rising healthcare expenditure, and the adoption of advanced medical technologies. Moreover, the market in the Middle East and Africa is expanding due to increasing investments in healthcare infrastructure, a rising prevalence of eye diseases, and growing awareness about eye health.

Competitive Landscape:

At present, the major ophthalmic devices and equipment market players are concentrating on innovation and collaborations to improve their market positioning. Several companies are investing substantially in R&D to introduce cutting-edge technologies for detecting and curing eye conditions. Furthermore, vendors further expand their product offerings, through partnerships and acquisitions with other market majors, to provide the new and increasing requirements of patients and new target markets with further opportunities for expansion and market competitiveness. For instance, on April 26, 2024, the Bausch and Lomb Corporation, a leading company dedicated to improving eye health and enhancing the quality of life of patients, reported that the U.S. Food and Drug Administration has approved the company's LUMIFY Preservative Free, the eye drop that can remove redness. This is the first and only fully over-the-counter preservative-free eye drop with over-the-counter low-dose brimonidine tartrate that can be used to combat ocular redness caused by small eye irritations.

The report provides a comprehensive analysis of the competitive landscape in the global ophthalmic devices market with detailed profiles of all major companies, including:

• Alcon Inc
• Bausch + Lomb Surgical
• EssilorLuxottica SA
• Haag-Streit Group
• HOYA Surgical Optics
• Leica Microsystems
• Nidek Co., Ltd.
• Topcon Corporation
• Volk Optical
• ZEISS Medical Technology
• Ziemer Ophthalmic Systems AG

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global ophthalmic devices market in 2025?

2. What is the expected growth rate of the global ophthalmic devices market during 2026-2034?

3. What are the key factors driving the global ophthalmic devices market?

4. What has been the impact of COVID-19 on the global ophthalmic devices market?

5. What is the breakup of the global ophthalmic devices market based on the product type?

6. What is the breakup of the global ophthalmic devices market based on the end use?

7. What are the key regions in the global ophthalmic devices market?

8. Who are the key players/companies in the global ophthalmic devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Ophthalmic Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Surgical
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Implants
    • 6.1.2.2 Consumables
    • 6.1.2.3 Equipment
  • 6.1.3 Market Forecast
• 6.2 Vision Care
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Contact Lens
    • 6.2.2.2 Ocular Health
  • 6.2.3 Market Forecast

7 Market Breakup by Application

• 7.1 Cataract
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Vitreo Retinal Disorders
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Glaucoma
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Refractor Disorders
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End Use

• 8.1 Hospitals and Eye Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Academic and Research Laboratory
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Alcon Inc
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Bausch + Lomb Surgical
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 SWOT Analysis
  • 14.3.3 EssilorLuxottica SA
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
  • 14.3.4 Haag-Streit Group
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 HOYA Surgical Optics
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Leica Microsystems
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Nidek Co., Ltd.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 SWOT Analysis
  • 14.3.8 Topcon Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Volk Optical.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 ZEISS Medical Technology
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Ziemer Ophthalmic Systems AG
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio